Pregnancy during Ustekinumab Treatment for Severe Psoriasis

Publisher： Karger

E-ISSN： 1421-9832|231|2|103-104

ISSN： 1018-8665

Source： Dermatology, Vol.231, Iss.2, 2015-03, pp. : 103-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Ustekinumab in Palmoplantar Psoriasis

By  

Dermatology, Vol. 221, Iss. 4, 2010-10 ,pp. : 321-323

Karger

Access to resources Recommend Favorite

Long-Term Efficacy, Safety and Drug Survival of Ustekinumab in a Spanish Cohort of Patients with Moderate to Severe Plaque Psoriasis

By  

Dermatology, Vol. 230, Iss. 1, 2015-01 ,pp. : 46-54

Karger

Access to resources Recommend Favorite

Ustekinumab Induces Fast Response and Maintenance of Very Severe Refractory Scalp Psoriasis: Results in Two Greek Patients from the Psoriasis Hospital-Based Clinic

By  

Dermatology, Vol. 228, Iss. 2, 2014-02 ,pp. : 107-111

Karger

Access to resources Recommend Favorite

Treatment of Psoriasis with Anti-TNF Drugs during Pregnancy: Case Report and Review of the Literature

By  

Dermatology, Vol. 220, Iss. 1, 2009-11 ,pp. : 71-76

Karger

Access to resources Recommend Favorite

Ustekinumab Treatment of TNF Antagonist-Induced Paradoxical Psoriasis Flare in a Patient with Psoriatic Arthritis: Case Report and Review

By  

Dermatology, Vol. 225, Iss. 1, 2012-08 ,pp. : 14-17

Karger

Access to resources Recommend Favorite